Search results for "HK inno.N"

HK inno.N's K-CAB Secures Sixth Indication to Prevent Ulcers from Long-Term NSAID Use

HK inno.N's K-CAB Secures Sixth Indication to Prevent Ulcers from Long-Term NSAID Use

HK inno.N’s gastroesophageal reflux disease drug K-CAB has expanded its approved uses to include the prevention of gastric and duodenal ulcers...
HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial

HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial

HK inno.N announced on June 9 that its obesity drug candidate, ecnoglutide, demonstrated superior weight-loss efficacy compared to semaglutide—the...
HK inno.N’s ‘Ecnoglutide’: Can a Late Entrant’s “Hidden Card” Reshape the Obesity Market?

HK inno.N’s ‘Ecnoglutide’: Can a Late Entrant’s “Hidden Card” Reshape the Obesity Market?

HK inno.N is fast-tracking the South Korean launch of ecnoglutide, a GLP-1 receptor agonist licensed from China’s...
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval

K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval

South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with...
HK Innoen's 'K-Cab' Applies for New Drug Approval from the U.S. FDA

HK Innoen's 'K-Cab' Applies for New Drug Approval from the U.S. FDA

HK Innoen announced on the 13th that its U.S. partner, Sevela Pharmaceuticals, a subsidiary and specialist in...
HK Innoen Launches Four New 'Zero Sugar' Condition Products

HK Innoen Launches Four New 'Zero Sugar' Condition Products

HK Innoen announced on the 7th that it will launch new hangover relief beverages, including three types of stick jelly...
Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%

Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%

Hanmi Pharmaceutical posted a sharp profit surge in the second quarter of this year, buoyed by a major...
117 Workplace Accidents Recognized at 25 Major Korean Pharma and Biotech Firms Over Five Years

117 Workplace Accidents Recognized at 25 Major Korean Pharma and Biotech Firms Over Five Years

A review of 25 major South Korean pharmaceutical and biotechnology companies revealed 117 recognized industrial...
K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge

K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge

More than 10 South Korean pharmaceutical companies are pivoting toward veterinary medicine as a strategic growth engine.